ANI Pharmaceuticals to Discuss Third Quarter 2022 Financial Results on November 9, 2022, at 8:00 a.m. ET
October 24 2022 - 6:50AM
Business Wire
ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ:
ANIP) today announced that the Company will release its third
quarter 2022 financial results on Wednesday, November 9, 2022,
prior to market open.
Nikhil Lalwani, President and Chief Executive Officer, and
Stephen P. Carey, Senior Vice President, Finance, and Chief
Financial Officer, will host a conference call to discuss the
results as follows:
Date
Wednesday, November 9, 2022
Time
8:00 a.m. ET
Toll free (U.S.)
800-245-3047
Webcast (live and replay)
www.anipharmaceuticals.com, under the
“Investors” section
A replay of the conference call will be available within two
hours of the call’s completion and will remain accessible for two
weeks by dialing 800-753-6120 and entering access code 1159760.
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical
company serving patients in need by developing, manufacturing, and
marketing high quality branded and generic prescription
pharmaceutical products, including for diseases with high unmet
medical need. Our team is focused on delivering sustainable growth
by building a successful Purified Cortrophin® Gel franchise,
strengthening our generics business with enhanced development
capability, innovation in established brands and leveraging our
North American manufacturing capabilities. For more information,
please visit our website www.anipharmaceuticals.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221024005339/en/
Investor Relations: Lisa M. Wilson, In-Site
Communications, Inc. 212-452-2793 lwilson@insitecony.com
Media: Faith Pomeroy-Ward, ANI Pharmaceuticals
817-807-8044 Faith.pomeroyward@anipharmaceuticals.com
ANI Pharmaceuticals (NASDAQ:ANIP)
Historical Stock Chart
From Mar 2024 to Apr 2024
ANI Pharmaceuticals (NASDAQ:ANIP)
Historical Stock Chart
From Apr 2023 to Apr 2024